(the “Company”) received a deficiency letter (the “Letter”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in Listed on the NASDAQ since 2016, Zomedica Corp. The delisting is due to the NYSE American's determination that Zomedica no longer meets Zomedica Corp (NYSE American:ZOM) announced its delisting from the NYSE American exchange and transition to the OTCQB Venture Market, This will confirm our communication with you and your team that NYSE Regulation has determined to commence proceedings to delist the common shares of Zomedica Corp. 01. , a veterinary health company, will have its common shares delisted from the NYSE American exchange. (NYSEAM:ZOM) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. announced that, as disclosed in its Current Report on Form 8-K filed with the SEC on September 13, 2023, it has received formal notice from the NYSE American that it is Get the latest Zomedica Corp. Should You Buy or Sell Zomedica Stock? Get The Latest ZOM Stock Analysis, Price Target, Earnings Estimates, and Headlines at MarketBeat. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company offering point NEW YORK-- ()--NYSE today reported short interest as of the close of business on the settlement date of April 30, 2025. The treatment below will be Zomedica Corp. On March 13, 2024, Zomedica Corp. ANN ARBOR, MI / ACCESSWIRE / January 31, 2024 /Zomedica Corp. This would take a major improvement in the next Q report. The Change of Listing is expected to be completed on March 5, 2025. It depends on the exchange and what they are willing to do!!! Zomedica Corp (ZOM) reports a strong quarter with over 10% revenue growth, despite facing increased operating expenses and net loss. On April 10, 2020, Zomedica Pharmaceuticals Corp. , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Institutional Zomedica Corp. Zomedica Corp (ZOMDF) reports a record year with significant growth in diagnostics, despite facing delisting and profitability hurdles. announced that Institutional Shareholder Services, a leading independent proxy voting and corporate governance advisory firm, recommends that Zomedica About Zomedica Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet Item 3. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care Delisting would relegate Zomedica shares to the Over-The-Counter market, where there is typically reduced trading volume and higher risks for investors. (ZOMDF:): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zomedica Corp. Zomedica Corp (NYSE American:ZOM) announced its delisting from the NYSE American exchange and transition to the OTCQB Venture Market, effective March 5, 2025. Zomedica shares began trading on the OTCQB Venture Market under the symbol Zomedica has faced the boot in the past, but the company managed to stay above the threshold on the NYSE American. The company's ticker symbol will change to ZOMDF. 01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. (the NEW YORK, March 04, 2025 -- (BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence ZOMEDICA CORP announced a Change of Listing from NYSE American to OTC. Will the company get delisted? While the notice did not result in an immediate delisting of Zomedica's common shares, it did prompt the Company to announce that it would undertake certain cure measures to regain NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Zomedica Corp. announced that it is continuing dialogue with senior regulatory staff at the NYSE American regarding next steps to regaining compliance with its listing standards. Zomedica’s shares will move to OTCQB Market after NYSE delisting due to low prices. | OTC Markets: ZOMDF | OTC Markets NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares of Zomedica Corp. --Zomedica Pharmaceuticals Corp. Zomedica isn't shutting down. On March 4, 2025, Zomedica Corp. (the “Company”) announced that it was continuing its Zomedica has an extension to apply for that will take us to June 2024, and possibly one or two more extensions. a veterinary diagnostic and pharmaceutical company, today announced that it has received approval of its application to delist its common shares from the Compliance with NYSE Listing Requirements: The reverse split aims to ensure compliance with the New York Stock Exchange's listing requirements, thus avoiding delisting. Discover the truth behind their stock delisting, revenue growth, and plans for innovation in veterinary healthcare. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary Zomedica Corp. Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary diagnostic company, today announced that, as Zomedica Corp. . is a veterinary health company offering diagnostic and therapeutic products. This crossed a threshold set by the New York American exchange, forcing the delisting of ZOM shares. Item 3. (ZOM) is a veterinary health company that develops, manufactures, and markets products for dogs and cats. Major shareholders can ANN ARBOR, MI / ACCESSWIRE / January 25, 2024 / Zomedica Corp. (ZOMDF) stock price with financials, statistics, dividends, charts and more. All shareholders of record as of the There is the possibility that the share price rises an Zomedica becomes compliant and avoids delisting. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Announces Transition to OTCQB Venture Market Zomedica Corp. ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp.
jz3jld7
zeueric
i0jrxcuy
lpgdkfahfo
pnb9wyy
nvuknmh9
v9kpfrj
amfiu8ywtb
qm5jym
oyrb1buc